Merck KGaA (OTCMKTS:MKGAF – Get Free Report) is projected to issue its results before the market opens on Thursday, March 5th. Analysts expect the company to announce earnings of $2.29 per share and revenue of $6.1553 billion for the quarter.
Merck KGaA Trading Down 6.5%
OTCMKTS:MKGAF opened at $143.75 on Wednesday. The company has a market cap of $18.58 billion, a P/E ratio of 21.95 and a beta of 0.96. Merck KGaA has a twelve month low of $118.05 and a twelve month high of $159.34. The business has a 50 day moving average price of $150.31 and a two-hundred day moving average price of $139.64. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- New Copper-Rich “Kraken” Zone Discovered
- Silver Is the New Oil—And the World’s Running Dry
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
